AbbVie News

AbbVie (ABBV) Could Be a Great Choice

Yahoo FinanceJun 3 11:45 ET

AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

Yahoo FinanceJun 3 10:05 ET

TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades'

On CNBC's "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named The TJX Companies, Inc. (NYSE:TJX) as her final trade.On May 22, TJX Companies reported better-than-expect

BenzingaJun 3 08:30 ET

ASCO 2024: AbbVie Flexes Early Success of ADC Pipeline in Solid Tumours

Yahoo FinanceJun 3 04:25 ET

AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?

Yahoo FinanceJun 3 02:33 ET

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

NORTH CHICAGO, Ill., June 3, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Robert A. Michael, pre

abbvieJun 3 00:00 ET

Strong Financial Outlook and Strategic Initiatives Underpin Buy Rating for AbbVie

TipRanksJun 2 21:15 ET

Emerging and Chinese Pharmas Playing Greater Role in Oncology Drug Development

Seeking AlphaJun 2 14:00 ET

Express News | NYSE Order Imbalance 1474682.0 Shares on Buy Side

ReutersMay 31 15:51 ET

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaMay 31 13:35 ET

Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal

Yahoo FinanceMay 31 13:01 ET

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday

Health care stocks were flat to higher pre-bell Friday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.2% recently. Summit Therapeutics (

MT NewswiresMay 31 09:19 ET

AbbVie Wins EU Backing for Skyrizi in Bowel Disorder

Seeking AlphaMay 31 07:10 ET

AbbVie Receives European Medicine Agency Committee's Recommendation for Approval of Severe Bowel Disease Drug Candidate

AbbVie (ABBV) said Friday that the European Medicines Agency's advisory committee recommended approval of risankizumab for treating adults with moderately to severely active ulcerative colitis who hav

MT NewswiresMay 31 04:34 ET

Express News | Abbvie Inc - Final European Commission Decision Is Expected in Q3 of 2024

ReutersMay 31 02:01 ET

Express News | Abbvie Receives Positive Chmp Opinion for Risankizumab (Skyrizi®) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis

ReutersMay 31 02:00 ET

Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz &...

Stockhouse May 30 12:00 ET

CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm

PHILADELPHIA, May 30, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) ("Cerevel") on behalf of the company's shareholders. O

PR NewswireMay 30 06:00 ET

Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?

Yahoo FinanceMay 29 16:32 ET

AbbVie Shares Fell for Seven Straight Days

Seeking AlphaMay 29 16:10 ET